Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia
Tom D. Y. Reijnders(Amsterdam University Medical Centers), Tom van der Poll(Amsterdam Neuroscience), Tjitske S. R. van Engelen(University of Amsterdam), Eleuterio Lombardo, Miguel Sánchez García(Hospital Clínico San Carlos), Daoud Sie(Amsterdam University Medical Centers), Brendon P. Scicluna(Academic Medical Center), Kevin Galinsky(Takeda (United States)), Bruno François(Inserm), Dmitry V. Ostanin(Takeda (United States)), Pierre-François Laterre(Cliniques Universitaires Saint-Luc), Joe M. Butler(Amsterdam University Medical Centers)
Cited by 7
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
Sepsis: a roadmap for future research
|The Lancet Infectious Diseases|2015|1k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976